Fig. 2From: (Secondary) solid tumors in thyroid cancer patients treated with the multi-kinase inhibitor sorafenib may present diagnostic challengesBRAF DNA sequencing. Identification of a rare BRAF mutation c.1799-1801het_delTGABack to article page